The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Medivation Inc

Nasdaq: MDVN
Last

(U.S.) $30.44

Today's change+1.86 +6.51%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.
 

Medivation Inc

Nasdaq: MDVN
Last

(U.S.) $30.44

Today's change+1.86 +6.51%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Medivation Inc up sharply

Medivation Inc closed up sharply Friday, rallying (U.S.)$1.86 or 6.51% to (U.S.)$30.44. Over the last five days, shares have gained 4.46%, but are down 37.03% for the last year to date. Shares have underperformed the S&P 500 by 30.77% during the last year.

Key company metrics

  • Open(U.S.) $28.70
  • Previous close(U.S.) $28.58
  • High(U.S.) $30.47
  • Low(U.S.) $28.05
  • Bid / Ask-- / --
  • YTD % change-37.03%
  • Volume3,198,067
  • Average volume (10-day)3,422,194
  • Average volume (1-month)2,653,978
  • Average volume (3-month)1,917,563
  • 52-week range(U.S.) $26.41 to (U.S.) $70.79
  • Beta0.94
  • Trailing P/E19.47×
  • P/E 1 year forward31.53×
  • Forward PEG0.54×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.56
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+31.71%

Based on its net profit margin of 31.71%, Medivation Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue261176129275
Total other revenue--------
Total revenue261176129275
Gross profit--------
Total cost of revenue--------
Total operating expense135130129131
Selling / general / administrative76758473
Research & development46474558
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)138----
Other operating expenses, total--------
Operating income126461143
Interest income (expense), net non-operating-1-5-6-6
Gain (loss) on sale of assets--------
Other--------
Income before tax12540-5138
Income after tax8026-3164
Income tax, total4515-2-26
Net income8026-3164
Total adjustments to net income--------
Net income before extra. items8026-3164
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items8026-3164
Inc. avail. to common incl. extra. items8026-3164
Diluted net income8026-3164
Dilution adjustment00--0
Diluted weighted average shares168169157172
Diluted EPS excluding extraordinary itemsvalue per share0.470.15-0.020.96
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.520.18-0.020.96